Levodopa and 3-O-Methyldopa in Cerebrospinal Fluid After Levodopa-Carbidopa Association

By Benetello P.   Furlanut M.   Fortunato M.   Pea F.   Baraldo M.  

Pharmacological Research, Vol. 35, Iss. 4, 1997-04 ,pp. : 313-315

Academic Press

Access to resources Recommend Favorite

Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy subjects

By Gasser U.E.   Crevoisier C.   Ouwerkerk M.   Lankhaar G.   Dingemanse J.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 46, Iss. 2, 1998-09 ,pp. : 223-228

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain

By Niesters Marieke   Dahan Albert  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1409-1417

Informa Healthcare

Access to resources Recommend Favorite

Kolaviron Modulates cellular redox status and impairment of membrane protein activities induced by potassium bromate (KBrO₃) in rats

By Olatunde Farombi E.   Alabi M.C.   Akuru T.O.  

Pharmacological Research, Vol. 45, Iss. 1, 2002-01 ,pp. : 63-68

Academic Press

Access to resources Recommend Favorite

A Study of the Biological Partitioning Behavior of n-Alkanes and n-Alkanols in Causing Anesthetic Effects

By Hau K.M.   Connell D.W.   Richardson B.J.  

Regulatory Toxicology and Pharmacology, Vol. 35, Iss. 2, 2002-04 ,pp. : 273-279

Academic Press

Access to resources Recommend Favorite